BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 9, 2001
View Archived Issues
Antitumor activity of new VEGFR2 inhibitor under study at Boehringer Ingelheim
Read More
Gilead achieves several key R&D milestones during Q3
Read More
Elan highlights Q3 developments
Read More
TAP prodrug of duocarmycin derivative shows increased tumor specificity
Read More
Rapid anthrax test will be available to U.S. laboratories next week
Read More
Alexion acquires rights to immune system targets
Read More
FDA issues nonapprovable letter for IntraDose
Read More
Early NDA submission planned for Cellegy's testosterone gel
Read More
FDA grants orphan drug status for Thymitaq in treatment of HCC
Read More
NeoOncoRx to develop and market elsamitrucin
Read More
Antiallergic effects of AZG-1743, a new diphenylmethyl piperazine derivative
Read More
Pirfenidone may be useful in asthma Rx according to data presented at recent Japanese meeting
Read More
Chest 2001: cilomilast reduces sputum neutrophil count in COPD patients
Read More
Clinical course of malignant pleural effusions in NSCLC not changed by rhuMAb-VEGF
Read More
Adenosine modulation by pentostatin shows beneficial effects in septic mice
Read More
Further subgroup analyses of PROWESS data presented at Chest 2001
Read More
TNFerade gene therapy + radiation safely shrinks tumors in phase I trial
Read More
Phase III trials of RSR-13 in NSCLC under consideration at Allos based on phase II survival data
Read More
New analgesic from Vita enters clinical trials
Read More
Cancer-related protease inhibitor from Wilex reduces tumor growth and spread at nontoxic doses
Read More
Novel compounds from Knoll inhibit monoamine reuptake, bind to 5-HT1A receptors
Read More
Recent patent covers BMS's new DPP-IV inhibitors
Read More
Carbamic acid-based IP receptor antagonists reportedly useful for bladder disorders, etc.
Read More
Aventis prepares beta-carboline inhibitor of IKK which prolongs cardiac graft survival
Read More
New series for obesity and sleep disorders disclosed by Actelion
Read More
Selective COX-2 inhibitors synthesized by Almirall Prodesfarma
Read More
Novel compounds described in recent patent as chemokine IL-8 antagonists
Read More